BioCentury | Mar 19, 2015
Targets & Mechanisms

Untangling α-synuclein

...Prana Biotechnology Ltd. 's PBT434 , NeuroPhage Pharmaceuticals Inc. 's NPT001 and ProteoTech Inc. 's synuclere...
BioCentury | Jan 2, 2012
Company News

ProteoTech, GlaxoSmithKline deal

...synucleinopathies. ProteoTech's lead product under the program, Synuclere , is in preclinical testing for PD. Synuclere...
Items per page:
1 - 2 of 2